{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:28:37Z","timestamp":1778722117518,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bmc.2024.117910","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:09:12Z","timestamp":1726124952000},"page":"117910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pegylation enhances the anti-osteoporosis activity of acacetin in both ovariectomized and LPS-stimulated mice"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4582-3797","authenticated-orcid":false,"given":"Linjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaojin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6673-5956","authenticated-orcid":false,"given":"Shipeng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117910_b0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","article-title":"Long-term and sequential treatment for osteoporosis","volume":"19","author":"Foessl","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bmc.2024.117910_b0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.21106","article-title":"Prevalence of osteoporosis and fracture in china: the china osteoporosis prevalence study","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bmc.2024.117910_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.675385","article-title":"The role of osteoclast energy metabolism in the occurrence and development of osteoporosis","volume":"12","author":"Da","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.bmc.2024.117910_b0020","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117910_b0025","article-title":"Acacetin inhibits inflammation by blocking MAPK\/NF-\u03baB pathways and NLRP3 inflammasome activation","volume":"8","author":"Bu","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2024.117910_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111708","article-title":"Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders","volume":"145","author":"Singh","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bmc.2024.117910_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153351","article-title":"Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of \u03b1v\u03b23 integrin and core-linked CD44","volume":"79","author":"Kim","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2024.117910_b0040","article-title":"Acacetin prevents bone loss by disrupting osteoclast formation and promoting type H vessel formation in ovariectomy-induced osteoporosis","volume":"19","author":"Lin","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"583","key":"10.1016\/j.bmc.2024.117910_b0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbrc.2021.10.066","article-title":"Acacetin inhibits RANKL-induced osteoclastogenesis and LPS-induced bone loss by modulating NFATc1 transcription","volume":"30","author":"Jin","year":"2021","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.bmc.2024.117910_b0050","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/13880209.2023.2207597","article-title":"Acacetin-loaded microemulsion for transdermal delivery: preparation, optimization and evaluation","volume":"61","author":"Wang","year":"2023","journal-title":"Pharm Biol"},{"key":"10.1016\/j.bmc.2024.117910_b0055","doi-asserted-by":"crossref","first-page":"16127","DOI":"10.1038\/srep16127","article-title":"Effects and possible mechanisms of action of acacetin on the behavior and eye morphology of Drosophila models of Alzheimer's disease","volume":"4","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"issue":"2022","key":"10.1016\/j.bmc.2024.117910_b0060","first-page":"53","article-title":"Evolution of drug delivery systems: From 1950 to 2020 and beyond","volume":"342","author":"Park","year":"1950","journal-title":"J Control Release"},{"key":"10.1016\/j.bmc.2024.117910_b0065","article-title":"PEGylated therapeutics in the clinic","volume":"9","author":"Gao","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.bmc.2024.117910_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ph16010002","article-title":"An acid-sensitive bone targeting delivery system carrying acacetin prevents osteoporosis in ovariectomized mice","volume":"16","author":"Sun","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bmc.2024.117910_b0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/dmd.106.012419","article-title":"PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies","volume":"35","author":"Webster","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmc.2024.117910_b0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bmc.2024.117910_b0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biot.200900218","article-title":"PEGylation of therapeutic proteins","volume":"5","author":"Jevsevar","year":"2010","journal-title":"Biotechnol J"},{"key":"10.1016\/j.bmc.2024.117910_b0090","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/S0021-9258(17)40291-2","article-title":"Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117910_b0095","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117910_b0100","article-title":"Acacetin prevents bone loss by disrupting osteoclast formation and promoting type H vessel formation in ovariectomy-induced osteoporosis","volume":"19","author":"Lin","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.bmc.2024.117910_b0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbrc.2021.10.066","article-title":"Acacetin inhibits RANKL-induced osteoclastogenesis and LPS-induced bone loss by modulating NFATc1 transcription","volume":"30","author":"Jin","year":"2021","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T16:30:54Z","timestamp":1728491454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624003249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":21,"alternative-id":["S0968089624003249"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117910","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pegylation enhances the anti-osteoporosis activity of acacetin in both ovariectomized and LPS-stimulated mice","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117910"}}